Cargando…
Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688184/ https://www.ncbi.nlm.nih.gov/pubmed/33251070 http://dx.doi.org/10.7759/cureus.11163 |
_version_ | 1783613661154115584 |
---|---|
author | Kaur, Gurleen Ashraf, Ibtisam Peck, Mercedes Maria Maram, Ruchira Mohamed, Alaa Ochoa Crespo, Diego Malik, Bilal Haider |
author_facet | Kaur, Gurleen Ashraf, Ibtisam Peck, Mercedes Maria Maram, Ruchira Mohamed, Alaa Ochoa Crespo, Diego Malik, Bilal Haider |
author_sort | Kaur, Gurleen |
collection | PubMed |
description | Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the subcortical white matter of parieto-occipital lobes. In this review, we will discuss the various etiologies and risk factors including some of the most common chemotherapeutic agents and immunosuppressant agents associated with this disorder. We will discuss the mechanism of actions and side effect profiles of a few drugs and their role in causation of PRES. This review article discusses if there is any difference in presentation and imaging findings of PRES caused by cytotoxic agents versus caused by other etiologies. It also highlights the difficulty in management of PRES caused by cytotoxic agents as the discontinuation of these drugs could be life-threatening due to graft rejections or graft versus host disease. |
format | Online Article Text |
id | pubmed-7688184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-76881842020-11-27 Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome Kaur, Gurleen Ashraf, Ibtisam Peck, Mercedes Maria Maram, Ruchira Mohamed, Alaa Ochoa Crespo, Diego Malik, Bilal Haider Cureus Neurology Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the subcortical white matter of parieto-occipital lobes. In this review, we will discuss the various etiologies and risk factors including some of the most common chemotherapeutic agents and immunosuppressant agents associated with this disorder. We will discuss the mechanism of actions and side effect profiles of a few drugs and their role in causation of PRES. This review article discusses if there is any difference in presentation and imaging findings of PRES caused by cytotoxic agents versus caused by other etiologies. It also highlights the difficulty in management of PRES caused by cytotoxic agents as the discontinuation of these drugs could be life-threatening due to graft rejections or graft versus host disease. Cureus 2020-10-25 /pmc/articles/PMC7688184/ /pubmed/33251070 http://dx.doi.org/10.7759/cureus.11163 Text en Copyright © 2020, Kaur et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Neurology Kaur, Gurleen Ashraf, Ibtisam Peck, Mercedes Maria Maram, Ruchira Mohamed, Alaa Ochoa Crespo, Diego Malik, Bilal Haider Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title | Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title_full | Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title_fullStr | Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title_full_unstemmed | Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title_short | Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome |
title_sort | chemotherapy and immunosuppressant therapy-induced posterior reversible encephalopathy syndrome |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688184/ https://www.ncbi.nlm.nih.gov/pubmed/33251070 http://dx.doi.org/10.7759/cureus.11163 |
work_keys_str_mv | AT kaurgurleen chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT ashrafibtisam chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT peckmercedesmaria chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT maramruchira chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT mohamedalaa chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT ochoacrespodiego chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome AT malikbilalhaider chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome |